| DAA2010 |
miR-221 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR221 |
— |
|
| DAA2008 |
miR-24 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR24-1 |
— |
|
| DAA2009 |
miR-24 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR24-2 |
— |
|
| DAA2611 |
miR-320b increases with age |
Molecular |
blood |
Human |
MIR320B1 |
1049.9% Increase miRNA Level |
|
| DAA2612 |
miR-320b increases with age |
Molecular |
blood |
Human |
MIR320B2 |
1049.9% Increase miRNA Level |
|
| DAA2610 |
miR-320d increases with age |
Molecular |
blood |
Human |
MIR320D2 |
529.9% Increase miRNA Level |
|
| DAA2609 |
miR-320d increases with age |
Molecular |
blood |
Human |
MIR320D1 |
529.9% Increase miRNA Level |
|
| DAA2011 |
miR-496 expression decreases with age |
Molecular |
blood, immune system |
Human |
MIR496 |
— |
|
| DAA2597 |
Mitochondrial DNA content in non-centenerians decreases with age |
Physiological |
blood |
Human |
— |
— |
|
| DAA2058 |
Mosaic abnormalities increase |
Physiological |
blood, oral cavity |
Human |
— |
— |
|
| DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA587 |
Septicemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
| DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
| DAA2432 |
sperm associated antigen 7 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SPAG7 |
26.2% Decrease DNA Methylation |
|
| DAA2438 |
syncoilin; intermediate filament 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SYNC |
21.4% Increase DNA Methylation |
|
| DAA2450 |
casein kappa increases with age |
Molecular |
mesenchymal stem cell |
Human |
CSN3 |
16.3% Increase DNA Methylation |
|
| DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
| DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZMYND8 |
19.9% Increase DNA Methylation |
|
| DAA2447 |
protein kinase N1 isoform 2 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PKN1 |
27.7% Increase DNA Methylation |
|
| DAA2461 |
calcyphosine isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPS |
17.3% Decrease DNA Methylation |
|
| DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
WISP2 |
23.5% Decrease DNA Methylation |
|
| DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|